Venus Remedies Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock of Venus Remedies Ltd fell sharply to Rs 1,634.9, hitting the lower circuit limit of 5.0% on the BE series. This price band capped the maximum daily loss allowed, effectively freezing trading at the floor price. The total traded volume was 0.71332 lakh shares, with a turnover of approximately Rs 11.93 crore. Despite this turnover, the presence of unfilled supply was evident as sellers queued up without buyers stepping in, a hallmark of lower circuit events. This scenario is particularly significant given the stock’s micro-cap status, with a market capitalisation of Rs 2,311 crore, where liquidity constraints exacerbate exit difficulties. With unfilled sell orders at Rs 1,634.9 and near-zero liquidity, how deep is the exit problem for Venus Remedies Ltd and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Contrary to what might be expected in a capitulation scenario, delivery volumes on 3 Jul 2026 fell by 40.75% compared to the 5-day average, registering only 2.59 thousand shares delivered. This decline in delivery volume suggests that the selling pressure may be driven more by speculative short-selling rather than genuine liquidation of holdings. On a lower circuit day, rising delivery volumes typically indicate holders offloading actual positions, but here the reduced delivery points to a different dynamic. The weighted average price also skewed closer to the day’s low, reinforcing the dominance of selling interest near the circuit floor. Does this divergence between falling delivery and lower circuit price indicate a temporary technical imbalance or a deeper structural weakness?

Intraday Price Action

The intraday range for Venus Remedies Ltd spanned from a high of Rs 1,750 to the circuit low of Rs 1,634.9, representing a 6.6% swing within the session. The stock opened near the upper end of this range but steadily declined throughout the day, culminating in the circuit lock. This gradual descent rather than an abrupt gap-down suggests persistent selling pressure that overwhelmed any intermittent buying interest. The fact that the stock closed at the circuit floor indicates that sellers were unable to find buyers at any price above Rs 1,634.9, reinforcing the unfilled supply narrative. Is this intraday collapse a sign of capitulation or a prelude to further downside?

Moving Averages and Trend Context

Technically, Venus Remedies Ltd is positioned below its 5-day and 20-day moving averages, signalling short-term weakness. However, it remains above the 50-day, 100-day, and 200-day moving averages, indicating that the longer-term trend has not yet fully turned bearish. This mixed moving average configuration suggests that while recent sessions have seen selling pressure intensify, the stock has not yet confirmed a sustained downtrend. The current lower circuit event may therefore represent an acceleration of recent weakness rather than a complete trend reversal. Below all moving averages and now locked at lower circuit — does the technical profile of Venus Remedies Ltd show any support level nearby, or is the next floor lower still?

Liquidity and Exit Risk

As a micro-cap stock, Venus Remedies Ltd faces inherent liquidity challenges. The stock’s liquidity profile allows a trade size of approximately Rs 0.27 crore based on 2% of the 5-day average traded value. While this is sufficient for small trades, any meaningful position faces significant exit friction, especially on a lower circuit day when supply overwhelms demand. The circuit lock not only capped losses but also trapped sellers who arrived too late to exit, potentially prolonging the period of price stagnation. This liquidity constraint is a critical factor for investors to consider, as it can lead to multi-day circuit locks and heightened volatility. After a 5.0% single-day loss at lower circuit, is Venus Remedies Ltd approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by innovation and regulatory complexity. Despite the recent price weakness, the company maintains a micro-cap market capitalisation of Rs 2,311 crore. The sector itself showed modest gains on the day, with a 0.27% rise, while the Sensex advanced 0.53%, underscoring the stock-specific nature of the decline. The stock has underperformed its sector by 5.34% today and has recorded a 6.81% loss over the past two days, reflecting sustained selling pressure.

Conclusion: Severity and Liquidity Caveats

The 5.0% lower circuit lock for Venus Remedies Ltd highlights a session where supply overwhelmed demand to the point that the exchange floor intervened to halt further losses. The falling delivery volumes suggest speculative selling rather than wholesale liquidation, but the micro-cap status and limited liquidity amplify exit risks for holders. The stock’s position below short-term moving averages confirms recent weakness, while the intraday price arc from Rs 1,750 to Rs 1,634.9 illustrates persistent selling pressure throughout the session. This combination of factors points to a challenging environment for sellers, who may remain trapped until liquidity improves. Locked at lower circuit with sellers queuing — is this capitulation or just the beginning for Venus Remedies Ltd? The multi-factor analysis has the answer.

Key Data at a Glance

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →